Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum β-lactamases in outpatient urinary E. coli between 2003 and 2008

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 1, 2010, Pages 87-91

  Qi, Chao ^a,b   Pilla, Varun ^c   Yu, Jessica H ^d   Reed, Kurt ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c ILLINOIS MATHEMATICS AND SCIENCE ACADEMY   (United States)

^d Northville High School   (United States)

Author keywords

CTX M; E. coli; ESBL

Indexed keywords

ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAMASE CTX M; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NITROFURANTOIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; IN VITRO STUDY; NONHUMAN; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; URINARY TRACT INFECTION; URINE CULTURE;

AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENOTYPE; HUMANS; NITROFURANTOIN; PREVALENCE; URINARY TRACT INFECTIONS; URINE; UROPATHOGENIC ESCHERICHIA COLI;

EID: 77951498390     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.12.011     Document Type: Article

References (24)

1. Canton R., Coque T.M. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 2006, 9:466-475.
2. Castanheira M., Mendes R.E., Rhomberg P.R., Jones R.N. Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007). Microb. Drug. Resist. 2008, 14:211-216.
3. Hanson N.D., Moland E.S., Hong S.G., Propst K., Novak D.J., Cavalieri S.J. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob. Agents Chemother. 2008, 52:3814-3816.
4. Ho P.L., Poon W.W., Loke S.L., Leung M.S., Chow K.H., Wong R.C., Yip K.S., Lai E.L., Tsang K.W. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J. Antimicrob. Chemother. 2007, 60:140-144.
5. Institute C.a.L.S.(CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7 2006, CLSI, Wayne, PA. 7th ed.
6. Institute C.a.L.S.(CLSI) Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Approved standard M100-S15 2007, CLSI, Wayne, PA.
7. Lewis J.S., Herrera M., Wickes B., Patterson J.E., Jorgensen J.H. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 2007, 51:4015-4021.
8. Livermore D.M., Canton R., Gniadkowski M., Nordmann P., Rossolini G.M., Arlet G., Ayala J., Coque T.M., Kern-Zdanowicz I., Luzzaro F., Poirel L., Woodford N. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 2007, 59:165-174.
9. Moland E.S., Black J.A., Hossain A., Hanson N.D., Thomson K.S., Pottumarthy S. Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five US States. Antimicrob. Agents Chemother. 2003, 47:2382-2383.
10. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control. 2004, 32:470-485. National Nosocomial Infections Surveillance System.
11. Olson A.B., Silverman M., Boyd D.A., McGeer A., Willey B.M., Pong-Porter V., Daneman N., Mulvey M.R. Identification of a progenitor of the CTX-M-9 group of extended-spectrum beta-lactamases from Kluyvera georgiana isolated in Guyana. Antimicrob. Agents Chemother. 2005, 49:2112-2115.
12. Paterson D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control. 2006, 34:S20-S28. discussion S64-S73.
13. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 2005, 18:657-686.
14. Pitout J.D., Nordmann P., Laupland K.B., Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 2005, 56:52-59.
15. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 2008, 8:159-166.
16. Pitout J.D., Chow B.L., Gregson D.B., Laupland K.B., Elsayed S., Church D.L. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates. J. Clin. Microbiol. 2007, 45:294-298.
17. Pournaras S., Ikonomidis A., Sofianou D., Tsakris A., Maniatis A.N. CTX-M-type beta-lactamases affect community Escherichia coli treatment, Greece. Emerg. Infect. Dis. 2004, 10:1163-1164.
18. Qi C., Malczynski M., Parker M., Scheetz M.H. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J. Clin. Microbiol. 2008, 46:1106-1109.
19. Rodriguez M.M., Power P., Radice M., Vay C., Famiglietti A., Galleni M., Ayala J.A., Gutkind G. Chromosome-encoded CTX-M-3 from Kluyvera ascorbata: a possible origin of plasmid-borne CTX-M-1-derived cefotaximases. Antimicrob. Agents Chemother. 2004, 48:4895-4897.
20. Ruppe E., Hem S., Lath S., Gautier V., Ariey F., Sarthou J.L., Monchy D., Arlet G. CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerg. Infect. Dis. 2009, 15:741-748.
21. Saladin M., Cao V.T., Lambert T., Donay J.L., Herrmann J.L., Ould-Hocine Z., Verdet C., Delisle F., Philippon A., Arlet G. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett. 2002, 209:161-168.
22. Shibata N., Kurokawa H., Doi Y., Yagi T., Yamane K., Wachino J., Suzuki S., Kimura K., Ishikawa S., Kato H., Ozawa Y., Shibayama K., Kai K., Konda K., Arakawa Y. PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob. Agents Chemother. 2006, 50:791-795.
23. Walther-Rasmussen J., Hoiby N. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases. Can. J. Microbiol. 2004, 50:137-165.
24. Woodford N., Ward M.E., Kaufmann M.E., Turton J., Fagan E.J., James D., Johnson A.P., Pike R., Warner M., Cheasty T., Pearson A., Harry S., Leach J.B., Loughrey A., Lowes J.A., Warren R.E., Livermore D.M. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J. Antimicrob. Chemother. 2004, 54:735-743.